This took the form of a nearly 5-million strong, secondary share issue. Nektar Therapeutics (NASDAQ: NKTR) saw its stock price erode on Thursday, following the company’s closing of a secondary stock …
Why Nektar Therapeutics Stock Dived by 3% Today
view original post